Tuesday, January 16, 2018
IRVINE, Calif., Nov. 09, 2017 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ:CDXC), a science-based, fully integrated nutraceutical company devoted to extending human healthspan, announced today the financial results for the quarter ended September 30, 2017. Frank Jaksch, Jr., CEO and co-founder of ChromaDex commented, “The science continues to...
IRVINE, Calif., June 12, 2017 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ:CDXC), an innovator of proprietary health, wellness and nutritional ingredients that creates science-based solutions for dietary supplement, food and beverage, skin care, sports nutrition, and pharmaceutical products announced today that it has signed...
ChromaDex (CDXC) reported earnings yesterday. As expected, they lost money during this period where they are investing in the development of Tru Niagen as a potential blockbuster supplement. Looking beyond the bottom line, which is basically irrelevant at this...
IRVINE, Calif., June 05, 2017 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ:CDXC), an innovator of proprietary health, wellness and nutritional ingredients that creates science-based solutions for dietary supplement, food and beverage, skin care, sports nutrition, and pharmaceutical products announced today that Charles Brenner, PhD, the...
As we enter the new year it is very difficult not to be optimistic...borderline exuberant. The Tailwinds Select Portfolio has been on a tear lately, closing the year with a bang. If gaining 20% in the last two months...
As an investor in ChromaDex (CDXC), and a user of their lead product Tru Niagen, I'm a firm believer in the health benefits of Nicotinamide Riboside (NR). NR in its consumer form is more commonly known as Niagen, which is...
Tailwinds' Take: the implications of this study are potentially massive. It truly appears that NR has many positive effects and is well on its way to becoming a blockbuster supplement. No side effects, many benefits. There appears to be...
Tailwinds' Take: this completes the strategic financing. Li Ka-shing owns a chain of pharmacies and has incredible reach into Asia, including China. As such, the Company's retail product, Tru Niagen, is poised to see incredible growth. Expected news, but...
Tailwinds' Take: based on their "successful", to quote the Company, launch in Hong Kong, this is probably the first of several more markets that Watsons will open up to Tru Niagen. CDXC remains on track to have a blockbuster...
Tailwinds' Take: Watsons is a great partner. The Asian market is the largest for sales of supplements and Tru Niagen is poised to be a very big commercial success overseas. This is the first step towards massive growth for...
Follow

Follow this blog

Get every new post delivered right to your inbox.

Email address